SRZN Surrozen, Inc. Common · XNAS
21.90 -4.7% as of Jul 22, 14:55 ET
What's happening Live detector signal Generated 17:36 ET
Share structurereference + latest snapshot
Free float
4.1M
2026-01-22
Shares out
11.6M
latest detail
Market cap
$266.9M
ref price
Short interest
17.3%
2026-06-30
Float rotation
0.08×
latest signal
20d dollar vol
$4.4M
baseline
Filings and news
2026-07-22 14:55 ETSignalSurrozen, Inc. Common is down 4.7%, at 21.90, on $7.1M traded, 1.7× 20-day volume, 0.08× float rotation. Score 74. Primary driver: 7.9% float rotation.
2026-05-148-KCurrent report filed with SEC. SEC
2026-05-0610-QQuarterly report SEC
2026-05-068-KItem 2.02 — Results of operations and financial condition; Item 9.01 — Financial statements and exhibits SEC
2026-04-01DEF 14AProxy statement SEC
2026-03-30EFFECTPotential financing or dilution-related filing. SEC
2026-03-30424B5Potential financing or dilution-related filing. SEC
2025-08-08 17:21 ETGeneralSurrozen Reports Q2 Profit on Gains News
2024-06-12 08:30 ETAnalyst RatingSurrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling News
2024-06-10 08:30 ETFDA / ClinicalSurrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan News
2024-06-04 08:30 ETFDA / ClinicalSurrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis News
Latest detector signal74 High
Move
-4.7%
Dollar volume
$7.1M
Rel volume
1.7×
Float rotation
0.08×

Primary driver: 7.9% float rotation

$7.1M traded1.7x 20d volume7.9% float rotationmicrocaplow float